Filter
8845
Filtered Results: 8845
Text search:
drugs
Featured
Recommendations
727
New Publications
2183
Language
Document type
No document type
5113
Studies & Reports
1328
Guidelines
1101
Manuals
395
Strategic & Response Plan
263
Fact sheets
240
Training Material
146
Situation Updates
74
Infographics
61
Resource Platforms
49
Brochures
40
Online Courses
17
Videos
12
App
4
Dashboards/Maps
2
Countries / Regions
India
490
Global
314
Kenya
252
South Africa
200
Ethiopia
179
Nepal
172
Uganda
170
Western and Central Europe
165
Nigeria
163
Sierra Leone
154
Tanzania
133
Zambia
128
Liberia
123
Malawi
122
Latin America and the Carribbean
122
Rwanda
113
Bangladesh
111
Ghana
109
Africa
108
Ukraine
106
Myanmar / Burma
103
Eastern Europe
87
Namibia
86
Indonesia
74
Philippines
71
Russia
69
Zimbabwe
64
Congo, Democratic Republic of
62
Asia
56
Senegal
53
South–East Asia Region
51
Syria
48
Cambodia
48
Lesotho
47
Mozambique
47
Germany
47
Brazil
43
Burkina Faso
42
Botswana
39
South Sudan
38
Haiti
37
Colombia
36
Venezuela
33
West and Central Africa
31
Eswatini/ Swaziland
31
East and Southern Africa
30
Middle East and North Africa
28
Cameroon
27
Guinea
24
Tajikistan
22
Chile
22
Paraguay
22
Eastern Europe and Central Asia
20
Argentina
20
Benin
19
Peru
19
USA
17
Vietnam
17
Yemen
17
Albania
16
Afghanistan
16
Sudan
16
Moldova
15
Pakistan
15
Bolivia
14
Madagascar
14
Thailand
13
Central African Republic
13
China
12
Georgia
12
Laos
11
Armenia
11
Western Pacific Region
11
Lebanon
11
Somalia
11
North Macedonia
10
North America
9
Sri Lanka
9
Mali
9
Ecuador
9
Mexico
8
El Salvador
8
Jordan
7
United Kingdom
7
Angola
7
Palestine
6
Libya
6
Iraq
6
Serbia
5
Turkey
5
Iran
5
Burundi
5
Guinea-Bissau
5
Spain
5
Southern Africa
5
Côte d’Ivoire / Ivory Coast
5
Papua New Guinea
5
Romania
5
Chad
5
Bhutan
5
Timor Leste/ East Timor
4
Fiji
4
Estonia
4
Kyrgyzstan
4
Niger
4
Uzbekistan
4
Saudi Arabia
4
Jamaica
4
Egypt
4
Poland
4
Switzerland
3
Gambia
3
Kazakhstan
3
Morocco
3
Hungary
3
Uruguay
3
France
3
Belarus
3
Greece
3
Honduras
3
Canada
2
Singapore
2
Mongolia
2
Qatar
2
Lithuania
2
Ireland
2
Gabon
2
Turkmenistan
2
Belgium
2
Mauritius
2
Tunisia
2
Portugal
2
Nicaragua
2
Djibouti
2
Guatemala
2
North Korea
1
Australia
1
Togo
1
Congo-Brazzaville
1
Malaysia
1
Austria
1
Bulgaria
1
Italy
1
Dominican Republic
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
3428
Clinical Guidelines
710
Public Health
380
Women & Child Health
347
Key Resources
266
Capacity Building
144
Pharmacy & Technologies
93
Annual Report MEDBOX
2
Toolboxes
HIV
930
Mental Health
876
TB
763
COVID-19
499
NTDs
371
AMR
365
Pharmacy
269
NCDs
203
Caregiver
199
Ebola & Marburg
168
Rapid Response
154
Refugee
145
Malaria
141
Conflict
128
Disability
119
Planetary Health
119
Global Health Education
86
Health Financing Toolbox
83
Natural Hazards
57
Zika
38
Cholera
35
Polio
29
Specific Hazards
26
Social Ethics
24
South Sudan
2
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
Alcohol can be a source of enjoyment. However, it can also be a drug or a source of addiction, with negative consequences for your health and the people around you.
Accessed: 14.03.2019
Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (MVE)
recommended
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
Alcohol, medication, tobacco, illegal drugs, addictive behaviour
Second, revised edition with new layout
Juni 2014
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
SOP explaining how to complete a stock card in order to track the number (quantity) of drugs in the stores area.
Last revised 2015.
Original Word document on:
http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Stock%20Control%20Card_SOP.doc
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
The purpose of this document is to stop to irrational use/ over prescription of this reserve/
experimental/ emergency use authorisation drug Remdesivir. For this reason, Joint
Monitoring Group under Chairmanship of DGHS took into consideration findings of the
followi...
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
The Global status report on alcohol and health and treatment of substance use disorders presents a comprehensive overview of alcohol consumption, alcohol-related harm and policy responses as well as treatment capacities for alcohol and drug use disorders worldwide. The report is based on data collec...
The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at bot...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
Volume 2016 | Article ID 5310718 | https://doi.org/10.1155/2016/5310718. Buruli ulcer (BU) is a necrotizing cutaneous infection caused by Mycobacterium ulcerans. Early diagnosis is crucial to prevent morbid effects and misuse of drugs. We review developments in laboratory diagnosis of BU, discuss li...
